Plaque Psoriasis Treatment Market Size And Prediction By Leading Manufacturers According To Its Application And Types Till 2026

plaque psoriasis is the most common type of psoriasis and accounted for 80% to 90% of the total number of cases of psoriasis. plaque psoriasis is an autoimmune condition in which thick, red patches appear on the skin. These plaques usually appear on the knees, scalp and elbows; However, it can also appear on other body parts. This is itching, pain, and may bleed. The exact cause of psoriasis is unknown plaque.

View Report: https://www.transparencymarketresearch.com/plaque-psoriasis-treatment-market.html

Psoriasis triggers include infections, severe sunburns, stress, smoking, alcohol consumption, obesity, dry skin, and certain drugs. Common symptoms of plaque psoriasis include itching, pain, stinging sensation, and skin tightness. The diagnosis of plaque psoriasis is usually done with a thorough skin examination. Sometimes, a biopsy is also recommended to confirm the condition. The increase in the prevalence of psoriasis worldwide, increased spending on research in developing countries, a high level of clinical needs unmet in patients with psoriasis, a surge of awareness about the condition, and reimbursement policies favorable is the main factor that is projected to push the plaque psoriasis global maintenance market for the projection period. However, no disease modifying treatments available for the condition and current treatments provide symptomatic relief only. This factor acts as the primary holder of the treatment of plaque psoriasis global market.

The treatment of plaque psoriasis global market can be segmented based therapy, drug class and region. In terms of therapy, treatment of plaque psoriasis market can be classified into topical therapies, phototherapy, systemic agents, and biological therapy. Topical therapy segment dominated the market in 2017 and is projected to maintain its leadership position over the forecast period. This is due to topical therapy is considered the first line of treatment for plaque psoriasis. Phototherapy involves exposing the skin to UV rays under medical supervision. Phototherapy and systemic agents are usually prescribed as a topical therapy is inadequate. Based on the class of drugs, the treatment of plaque psoriasis global market can be categorized into TNF-α, IL-17 inhibitor, and the IL-12/23 inhibitor. TNF-α inhibitor segment dominated the market in 2017 because of safety profile and significant use in the treatment of plaque psoriasis. This segment is expected to maintain its leadership position between 2018 and 2026. The inhibitors of TNF-α blocking the body’s response to TNF, a protein produced by white blood cells, thus suppress inflammation. It is also used in the treatment of rheumatoid arthritis (RA), Crohn’s disease, psoriatic arthritis, ankylosing spondylitis, and psoriasis.

For More Details, Request A PDF Brochure Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=59793

In terms of area, the treatment of plaque psoriasis global market can be divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to account for a significant share of the global market during the forecast period.

The increase in the prevalence of plaque psoriasis in the United States and rich pipeline drugs are the main factors anticipated to drive the market in North America from 2018 to 2026. According to the National Psoriasis Foundation, nearly 7.5 million people in the US suffer from psoriasis, and plaque psoriasis is the most common type of this illnesses. According to the World Psoriasis Day consortium, 125 million people suffer from psoriasis worldwide. Plaque psoriasis treatment market in Asia Pacific is expected to grow at a high CAGR between 2018 and 2026. This can be attributed to an increase in research spending and the increase in awareness about the disease among the population.

Contact Us

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

This release was published on openPR.